Literature DB >> 12734719

Improved production of ( S)-ketoprofen ester hydrolase by a mutant of Trichosporon brassicae CGMCC 0574.

Hui-Yuan Wu1, Jian-He Xu, Duan Shen, Qi Xin.   

Abstract

An efficient screening method following UV mutagenesis yielded a high frequency of improved mutants of Trichosporon brassicae CGMCC 0574, a wild-type esterase-producer capable of enantioselectively hydrolyzing the ethyl ester of ketoprofen [2-(3-benzoylphenyl) propionic acid]. The mutant had an activity 1.8-fold higher than the wild type and was stable in its enzyme production for ten serial transfers. As the best single carbon source, isopropanol improved the specific activity of the enzyme 5-fold; and this did not result from the effect of cell permeabilization. An 18-h culture grown on a medium containing 0.5% glucose plus 0.5% isopropanol produced 3-fold as much esterase as a culture grown on 1% glucose.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12734719     DOI: 10.1007/s10295-003-0053-1

Source DB:  PubMed          Journal:  J Ind Microbiol Biotechnol        ISSN: 1367-5435            Impact factor:   3.346


  4 in total

1.  Isolation of an esterase-producing Trichosporon brassicae and its catalytic performance in kinetic resolution of ketoprofen.

Authors:  D Shen; J H Xu; P F Gong; H Y Wu; Y Y Liu
Journal:  Can J Microbiol       Date:  2001-12       Impact factor: 2.419

2.  Directed evolution of an esterase for the stereoselective resolution of a key intermediate in the synthesis of epothilones.

Authors:  U T Bornscheuer; J Altenbuchner; H H Meyer
Journal:  Biotechnol Bioeng       Date:  1998-06-05       Impact factor: 4.530

Review 3.  Enzymes in the synthesis of chiral drugs.

Authors:  A L Margolin
Journal:  Enzyme Microb Technol       Date:  1993-04       Impact factor: 3.493

4.  Biocatalytic preparation of enantiopure ( R)-ketoprofen from its racemic ester by a new yeast isolate Citeromyces matriensis CGMCC 0573.

Authors:  P-F Gong; H-Y Wu; J-H Xu; D Shen; Y-Y Liu
Journal:  Appl Microbiol Biotechnol       Date:  2002-03-15       Impact factor: 4.813

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.